Search

everythinglearnresearchcommunity

for

Search:↓

Basal cell carcinomas in mice can start from hair follicle stem cells and other skin cell types, depending on signaling levels.

ASLNC168501 may help treat hair loss by boosting hair follicle stem cell activity.

AP-1 controls tumor cell type by affecting key signaling pathways.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Resveratrol-loaded nanoparticles show promise for lung cancer treatment.

Lespedeza cuneata extract may help treat enlarged prostate.

Finasteride in lipid carriers improved hair growth in rats.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

Finasteride may be cost-effective for preventing prostate cancer in high-risk groups.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

Immune cells boost stem cell activity in hairy moles, causing more hair growth.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

PRSS35 enzyme may help start skin tumors and could be a target for cancer treatment.

HPV8 causes hair follicle stem cells to grow, leading to skin lesions.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

ASLNC168501 can help treat hair loss by restoring hair follicle stem cell function.

Latanoprost-loaded nanotransfersomes could help treat hair loss by promoting hair growth.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Certain proteins, Lgr5 and Lgr6, are important markers of adult stem cells and are involved in tissue repair and cancer development.

HPV8 causes skin cancer by expanding specific skin stem cells.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

NEDD4 and NEDD4L help control intestinal stem cells and prevent tumors by breaking down the LGR5 receptor.

Selenium shows promise in preventing and controlling prostate cancer.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.